|

Alzheimer's Disease Clinical Trials in Houston, TX

25 recruiting studies within 50 miles

Phase
Trial Phase Dist.
ACP-204 in Adults With Alzheimer's Disease PsychosisPhase 2/3<1 mi
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Phase 3<1 mi
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's TypePhase 3<1 mi
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's DiseaseN/A<1 mi
Longitudinal Early-onset Alzheimer's Disease Study Protocol—<1 mi
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)—<1 mi
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)Phase 3<1 mi
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesPhase 3<1 mi
Stem Cell Therapy for Early Alzheimer's DiseasePhase 1/2<1 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseasePhase 2<1 mi
Systemic and Central Inflammation in ADPhase 2<1 mi
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADPhase 3<1 mi
Phase II Clinical Trial of Interleukin-2 in ADPhase 2<1 mi
Epidemiology and Biomarker Study in Alzheimer's DiseasePhase 3<1 mi
Open-label Extension Study in Participants With Early Alzheimer's DiseasePhase 2<1 mi
Glutathione, Brain Metabolism and Inflammation in Alzheimer's DiseaseEarly 1<1 mi
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia—<1 mi
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 3<1 mi
Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's DiseaseN/A<1 mi
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Phase 315 mi
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)Phase 324 mi
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseasePhase 224 mi
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)Phase 224 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)Phase 324 mi
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 327 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.